Literature DB >> 10806527

Increased osteocyte apoptosis during the development of femoral head osteonecrosis in spontaneously hypertensive rats.

M Shibahara1, K Nishida, H Asahara, T Yoshikawa, S Mitani, Y Kondo, H Inoue.   

Abstract

We investigated the presence of osteocyte apoptosis in the necrotic trabeculae of the femoral head of spontaneously hypertensive rat (SHR) using the in situ nick end labeling (TUNEL) method and transmission electron microscopy. The occurrence of osteonecrosis and ossification disturbance was significantly higher in SHR compared with Wistar Kyoto (WKY) rats, and Wistar (WT) rats used as control animals (P < 0.01). A high population of TUNEL positive osteocytes was detected mainly in 10- and 15-week-old SHRs. Sectioned examination of the femoral head of SHRs and WKY rats by electron microscopy revealed apoptotic cell appearances such as aggregation of chromatin particles and lipid formation. In contrast, a positive reaction was significantly lower in osteocytes in the femoral heads of WT rats (P < 0.01). Our results indicate that apoptosis forms an important component of the global pathologic process affecting the femoral head of SHR, which leads to osteonecrosis in this region.

Entities:  

Mesh:

Year:  2000        PMID: 10806527     DOI: 10.18926/AMO/32287

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  12 in total

1.  Combined effect of tnf-α polymorphisms and hypoxia on steroid-induced osteonecrosis of femoral head.

Authors:  Yaosheng Liu; Weihao Jiang; Shubin Liu; Xiuyun Su; Shiguo Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

Review 3.  Association of TNF-α-308(G/A) and -238(G/A) polymorphisms with non-traumatic osteonecrosis of the femoral head risks: a meta-analysis.

Authors:  Yizhong Peng; Yuenan Liu; Donghua Huang; Wei Huang; Zengwu Shao
Journal:  Int Orthop       Date:  2018-03-07       Impact factor: 3.075

4.  A rat model of early stage osteonecrosis induced by glucocorticoids.

Authors:  Mohammad Amin Kerachian; Edward J Harvey; Denis Cournoyer; Terry Y Chow; Ayoub Nahal; Chantal Séguin
Journal:  J Orthop Surg Res       Date:  2011-12-21       Impact factor: 2.359

5.  Soluble epoxide hydrolase inhibitor can protect the femoral head against tobacco smoke exposure-induced osteonecrosis in spontaneously hypertensive rats.

Authors:  Jingyi Xu; Xing Qiu; Gary Yu; Maria Ly; Jun Yang; Rona M Silva; Xun Zhang; Mang Yu; Yinong Wang; Bruce Hammock; Kent E Pinkerton; Dewei Zhao
Journal:  Toxicology       Date:  2021-11-18       Impact factor: 4.571

Review 6.  Metabolic syndrome meets osteoarthritis.

Authors:  Qi Zhuo; Wei Yang; Jiying Chen; Yan Wang
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 7.  Avascular Necrosis of the Femoral Head: Are Any Genes Involved?

Authors:  Farzaneh Pouya; Mohammad Amin Kerachian
Journal:  Arch Bone Jt Surg       Date:  2015-07

8.  Potential involvement of p53 in ischemia/reperfusion-induced osteonecrosis.

Authors:  Chiaki Okuma; Takefumi Kaketa; Atsuhiko Hikita; Koichi Matsuda; Masaki Nakamura; Yuichi Nagase; Yasushi Oshima; Mitsuyasu Iwasawa; Yusuke Nakamura; Hisashi Kurosawa; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

9.  New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model.

Authors:  Mohammad Amin Kerachian; Denis Cournoyer; Edward J Harvey; Terry Y Chow; Louis R Bégin; Ayoub Nahal; Chantal Séguin
Journal:  Arthritis Res Ther       Date:  2010-06-25       Impact factor: 5.156

10.  iNOS expression and osteocyte apoptosis in idiopathic, non-traumatic osteonecrosis.

Authors:  Jun Wang; Ali Kalhor; Shifeier Lu; Ross Crawford; Jiang-Dong Ni; Yin Xiao
Journal:  Acta Orthop       Date:  2014-09-05       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.